Literature DB >> 16208430

Catastrophic thromboses and severe thrombocytopenia during heparin therapy in a patient with anti-phospholipid syndrome.

Lior Zeller1, Yaniv Almog, Ahron Tomer, Shaul Sukenik, Mahmoud Abu-Shakra.   

Abstract

Catastrophic anti-phospholipid syndrome (CAPS) is a medical emergency characterized by thromboses of multiple small vessels of internal organs and the brain. Herein we present a patient with primary anti-phospholipid syndrome who developed CAPS manifested by hepatic, renal and splenic artery thromboses, as well as cerebral venous thrombosis. The course was further complicated by severe thrombocytopenia and haemolytic anemia. Two episodes of catastrophic thrombosis developed within 24-36 h after the initiation of heparin therapy, suggesting a role of heparin in triggering thromboses. The patient had no anti-platelet-factor-4 antibodies in repeated measurements, making clinical diagnosis of heparin-induced thrombocytopenia unlikely. The possible role of heparin in induction of thromboses and its therapeutic implication are detailed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208430     DOI: 10.1007/s10067-005-0017-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

Review 1.  Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.

Authors:  R A Asherson; R Cervera; J C Piette; Y Shoenfeld; G Espinosa; M A Petri; E Lim; T C Lau; A Gurjal; A Jedryka-Góral; H Chwalinska-Sadowska; R J Dibner; J Rojas-Rodríguez; M García-Carrasco; J T Grandone; A L Parke; P Barbosa; C Vasconcelos; M Ramos-Casals; J Font; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

2.  Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors:  J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

Review 3.  Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.

Authors:  R A Asherson; R Cervera; J C Piette; J Font; J T Lie; A Burcoglu; K Lim; F J Muñoz-Rodríguez; R A Levy; F Boué; J Rossert; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  1998-05       Impact factor: 1.889

4.  Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome.

Authors:  D Lasne; R Saffroy; C Bachelot; A Vincenot; F Rendu; T Papo; M Aiach; J C Piette
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

Review 5.  The catastrophic antiphospholipid (Asherson's) syndrome in 2004--a review.

Authors:  Ronald A Asherson
Journal:  Autoimmun Rev       Date:  2005-01       Impact factor: 9.754

Review 6.  Heparin-induced thrombocytopenia.

Authors:  B H Chong
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

7.  Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies.

Authors:  Aaron Tomer
Journal:  J Lab Clin Med       Date:  2002-03

8.  A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia.

Authors:  A Tomer
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 9.  Pathogenesis of heparin-induced thrombocytopenia and thrombosis.

Authors:  Gowthami Arepally; Douglas B Cines
Journal:  Autoimmun Rev       Date:  2002-05       Impact factor: 9.754

10.  [Systemic lupus erythematosus and/or relapsing polychondritis with catastrophic antiphospholipid syndrome].

Authors:  M Roux; M Fabre; J Ninet
Journal:  Rev Med Interne       Date:  2004-01       Impact factor: 0.728

View more
  2 in total

1.  Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism.

Authors:  Samuel Adediran; Nicole Agostino
Journal:  Case Rep Hematol       Date:  2017-04-26

2.  Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature.

Authors:  Alba Jerez-Lienas; Alexis Mathian; Jenifer Aboab; Isabelle Crassard; Miguel Hie; Fleur Cohen-Aubart; Julien Haroche; Denis Wahl; Ricard Cervera; Zahir Amoura
Journal:  Brain Sci       Date:  2021-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.